Riskpilot← Back to searchSign inGet full accessAKAM AB
ABActiveOrg 5593416562Economic activity was not specified by tax authority · NACE 0000Est. 20210 employees
Revenue 2024
SEK 0
EBITDA margin
—
+16% vs 2023
Equity ratio
27.3%
Financial strength
Net profit 2024
SEK -67K
-121% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -28K | +16% |
| Net profit | SEK -67K | -121% |
| Total assets | SEK 1,2M | -17% |
| Equity | SEK 334K | -17% |
| Employees | 0 | — |
Legal name
AKAM AB
Org number
5593416562
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
20 oktober 2021
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att äga och förvalta aktier och andelar i dotter- och intressebolag samt därmed förenlig verksamhet.
Address
Email
alex.nordqvist@apoteksgruppen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | −31 | −33 | −28 |
| Depreciation & amort. | −0 | — | — |
| EBIT | −31 | −33 | −28 |
| Net financials | −18 | 275 | −39 |
| Profit before tax | −49 | 325 | −67 |
| Tax | −0 | — | — |
| Net profit | −49 | 325 | −67 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 1 225 | 1 474 | 1 220 |
| Equity | 76 | 401 | 334 |
| Long-term debt | 993 | 695 | 854 |
| Short-term debt | 155 | 379 | 32 |
| Total debt | 1 148 | 1 073 | 887 |
EBITDA margin
-2776100.0%
This company
15.8%
Market median
-17570353% vs market
20222024
Equity ratio
27.3%
This company
38.2%
Market median
-29% vs market
20222024
Return on equity
-20.0%
This company
18.4%
Market median
-209% vs market
20222024
Net profit margin
-6681800.0%
This company
8.1%
Market median
-82491458% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
2.66×
This company
0.62×
Market median
-329% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ME Chief Auditor | Chief Auditor | 2025 | — | — |
JL Chief Auditor | Chief Auditor | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AKAM AB 
AKAM Pharm i Mora ABBoard members of AKAM AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Elisabeth Terneblad | Chief Auditor | 0 companies |
| Jonas Lars Lindgren | Chief Auditor | 0 companies |
| Karam Salah Polus Deesha | Board of Directors | 0 companies |
| M H Charlotte Wiberg Larsson | Chairman | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Anders Nguyen | Deputy Board Member | 0 companies |
| Alex Nordqvist | Chairman | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Mansoor Nasiri | Board of Directors | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |